Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT00831597 is registered in ClinicalTrials.gov with Pharmatech as lead sponsor.

NCT NCT00831597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00831597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Lead sponsor
Pharmatech
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2008
Completion date
September 30, 2013
Enrollment
61 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b-cell lymphoma